AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels.
Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics.
It provides facemasks, undereye patches, blister shield foot care, hexagel, cracked heel repair patches, and fever patch.
The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019.
The company was founded in 1997 and is based in Langhorne, Pennsylvania.
Country | United States |
IPO Date | n/a |
Industry | Medical - Instruments & Supplies |
Sector | Healthcare |
Employees | 19 |
CEO | Adam R. Levy |
Contact Details
Address: 2150 Cabot Boulevard West Langhorne, Pennsylvania United States | |
Website | https://nexgel.com |
Stock Details
Ticker Symbol | NXGLW |
Exchange | NASDAQ |
Fiscal Year | n/a |
Reporting Currency | USD |
CIK Code | 0001468929 |
CUSIP Number | 65344E115 |
ISIN Number | US65344E1156 |
Employer ID | 26-4042544 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Adam R. Levy | Chief Executive Officer, President & Director |
Adam E. Drapczuk III | Chief Financial Officer |
Gregory Robb | Vice President of Operations |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jan 08, 2025 | 4 | Filing |
Jan 06, 2025 | 4 | Filing |
Jan 06, 2025 | 3 | Filing |
Jan 06, 2025 | 8-K | Current Report |
Dec 23, 2024 | 4 | Filing |
Nov 22, 2024 | 4 | Filing |
Nov 22, 2024 | 4 | Filing |
Nov 22, 2024 | 4 | Filing |
Nov 22, 2024 | 4 | Filing |
Nov 22, 2024 | 4 | Filing |